Lack of pharmacokinetic interaction of pantoprazole with diazepam in man

British Journal of Clinical Pharmacology

Volumn 42, Issue 2, 1996, Pages 249-252

  Gugler, R ^a,d   Hartmann, M ^b   Rudi, J ^a   Brod, I ^a   Huber, R ^b   Steinijans, V W ^b   Bliesath, H ^b   Wurst, W ^b   Klotz, U ^c  

^a Klinikum Karlsruhe   (Germany)

^b ALTANA PHARMA AG   (Germany)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^d STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

Diazepam; Interaction; Pantoprazole; Proton pump inhibitor

Indexed keywords

CYTOCHROME P450; DIAZEPAM; DRUG METABOLITE; NORDAZEPAM; PANTOPRAZOLE; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTERACTION; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0030016562     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.40619.x     Document Type: Article

References (10)

1. Aliment Pharmacol Ther 1994; 8 (suppl. 1). Management of acid-related diseases: focus on pantoprazole, ed Pounder RE, Peterson WL. Guest editors: M. Classen and G. Delle Fave.
2. Gugler R, Jensen JC. Omeprazole inhibits oxidative drug metabolism. Gastroenterology 1985; 89: 1235-1241.
3. Andersson T, Andren K, Cederberg C, Edvardsson G, Heggelund A, Lundborg P. Effect of omeprazole and cimetidine on diazepam plasma levels. Eur J Clin Pharmacol 1990; 39: 51-54.
4. Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR. The effect of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 1975; 55: 347-359.
5. +-ATPase inhibitor BY1023/SK&F96022 and its sulphone metabolite in serum or plasma by direct injection and fully automated precolumn sample cleanup. J Chromatogr 1990; 529: 389-401.
6. Steinijans VW, Hartmann M, Huber R, Radtke H. Lack of pharmacokinetic interaction as an equivalence problem. Int J Clin Pharmacol Ther Toxicol 1991; 29: 323-328.
7. Diletti E, Hauschke D, Steinijans VW. Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharmacol Ther Toxicol 1991; 29: 1-8.
8. Pue MA, Laroche J, Meinecke I, de Mey C. Pharmacokinetics of pantoprazole following single oral and intravenous administration to healthy male subjects. Eur Clin Pharmacol 1993; 44: 575-578.
9. Andersson T, Cederberg C, Edvarsson G, Heggelund A, Lundborg P. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Clin Pharmacol Ther 1990; 47: 79-85.
10. Lefebvre RA, Flouvat B, Karolac-Tamisier S, Moermann E, Van Ganse E. Influence of lansoprazole treatment on diazepam plasma concentrations. Clin Pharmacol Ther 1993; 44: 575-578.